Tag Archives: oncosec

zoom
-

A New Era of Cancer Care

Advances in science and technology have brought about a new wave of promising cancer immunotherapies, which harness the body’s immune system to detect and fight cancer. Researchers have coined immunotherapy as the “beginning to the end of cancer” and we continue to see the space flourish.

Continue reading

zoom
-

Interview with Cheddar: Solving Unmet Need in Melanoma

I had the great privilege of speaking with Cheddar about the importance of cancer immunotherapy and OncoSec’s role in the fight to end cancer. We discuss the advantages of intratumoral therapy, the future of cancer care, and how OncoSec is positioned to solve a great unmet need in oncology. Check out the full interview for more!

zoom
Oncosec quarterly update
-

OncoSec Quarterly Update: July 2016

At OncoSec, we are committed to providing timely corporate updates, including recent achievements and upcoming milestones. We are pleased to provide brief recaps of our conference calls to further expand our avenues of communication. We hope these continued activities enhance shareholder engagement, and I look forward to sharing more updates with you.

zoom
Dr. Holbrook Kohrt at DNA Vaccine Conference
-

Dr. Kohrt Adds Major Clout

Today I am proud to announce the appointment of Dr. Holbrook Kohrt to OncoSec’s Scientific Advisory Board. Holbrook is a brilliant physician and researcher with extensive knowledge in tumor immunology and clinical trial design.

Continue reading

zoom
-

2014 Annual Letter To OncoSec Shareholders

A Letter to Our Shareholders

This is an important moment in cancer immunotherapy and we believe OncoSec is poised to make a real impact. During this pivotal time, it is important that we outline the core fundamentals of our company and our technology, so that you as shareholders will understand why all of us here at OncoSec are excited for the future.

Continue reading

zoom
-

Building Relationships Between Biotech Corporations and Academia

I believe that integrating academic institutions with the research and development pipeline – and having access to their facilities and research potential – to be of major importance. With the foundation of the biotech industry situated in California and along the West Coast, the location offers an ideal pocket of innovation and growth, within the life science community. The areas of major consideration are the Bay Area, San Diego, and Seattle. These areas not only offer large, committed life science groups and thriving biotech companies and economies but also some of the best educational institutions in North America if not the world, when you look at the life sciences.

Continue reading